Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | 0.00% | -99.76% |
Oct. 24 | Biocept, Inc.(OTCPK:BIOC.Q) dropped from NASDAQ Composite Index | CI |
Oct. 19 | Biocept, Inc.(NasdaqCM:BIOC) dropped from S&P TMI Index | CI |
Financials (USD)
Sales 2021 | 61.25M | Sales 2022 | 25.86M | Capitalization | 9.04M |
---|---|---|---|---|---|
Net income 2021 | -2M | Net income 2022 | -32M | EV / Sales 2021 | 0.73 x |
Net cash position 2021 | 16.19M | Net cash position 2022 | 788K | EV / Sales 2022 | 0.32 x |
P/E ratio 2021 |
-18.9
x | P/E ratio 2022 |
-0.28
x | Employees | 50 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 100% |
Latest transcript on Biocept, Inc.
1 day | +9,900.00% | ||
3 months | -99.75% | ||
6 months | -99.99% | ||
Current year | -99.76% |
Managers | Title | Age | Since |
---|---|---|---|
Barbara Blouw
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Nathaniel Sweed
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | 60 | 22-03-07 |
1st Jan change | Capi. | |
---|---|---|
-99.76% | 262 | |
+1.64% | 13.05B | |
-13.95% | 7.32B | |
-4.01% | 5.15B | |
-0.04% | 4.58B | |
-32.93% | 4.47B | |
+0.39% | 4.27B | |
+16.88% | 2.85B | |
+3.24% | 2.55B | |
+11.39% | 1.92B |